Safety of EUS latex balloon use in patients with a latex allergy

Balloons are used in EUS to improve visualization. However, data on the safety of latex balloons in patients with latex allergies are limited, and nonlatex alternatives can be costly. We investigated the safety of latex balloon use during EUS. A retrospective review was conducted at a tertiary cente...

Full description

Saved in:
Bibliographic Details
Published inGastrointestinal endoscopy Vol. 99; no. 6; pp. 1032 - 1034
Main Authors Salame, Marita, Gleeson, Ferga C., Chandrasekhara, Vinay, Law, Ryan J., Rajan, Elizabeth, Iyer, Prasad G., Bofill-Garcia, Aliana, Ghanem, Omar M., Abu Dayyeh, Barham K., Ravi, Anupama, Storm, Andrew C., Vargas, Eric J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2024
Subjects
Online AccessGet full text
ISSN0016-5107
1097-6779
1097-6779
DOI10.1016/j.gie.2024.01.032

Cover

More Information
Summary:Balloons are used in EUS to improve visualization. However, data on the safety of latex balloons in patients with latex allergies are limited, and nonlatex alternatives can be costly. We investigated the safety of latex balloon use during EUS. A retrospective review was conducted at a tertiary center between 2019 and 2022. Patients with reported latex allergies who underwent linear EUS were included. Baseline demographics, EUS characteristics, and adverse events were collected. The primary outcome was the rate of adverse events. Eighty-seven procedures were performed on 57 unique patients (mean age, 65.3 ± 14.5 years). Latex balloons were used in 59 procedures (67.8%), with only 8 procedures (13.6%) using prophylactic medications. No adverse events occurred during or after procedures, regardless of medication use or history of anaphylaxis. The use of EUS latex balloons in patients with a latex allergy was associated with no adverse events.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0016-5107
1097-6779
1097-6779
DOI:10.1016/j.gie.2024.01.032